Meta Platforms
META
Oracle
ORCL
Strategy
MSTR
4
MARA Holdings
MARA
5
Toll Brothers
TOL
US Stock MarketDetailed Quotes
REGN Regeneron Pharmaceuticals
- 607.920
- +17.920+3.04%
Trading May 2 15:38 ET
65.63BMarket Cap15.45P/E (TTM)
615.609High599.080Low1.11MVolume600.000Open590.000Pre Close676.30MTurnover1.06%Turnover Ratio15.86P/E (Static)107.97MShares1209.64552wk High2.23P/B64.02BFloat Cap525.99052wk Low0.88Dividend TTM105.31MShs Float1209.645Historical High0.14%Div YieldTTM2.80%Amplitude4.604Historical Low607.657Avg Price1Lot Size
Regeneron Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -30.90%1.05B | -3.78%4.42B | 15.89%1.26B | 15.88%1.29B | -65.38%354M | 10.60%1.51B | -8.39%4.59B | -36.64%1.09B | 77.18%1.11B | 81.15%1.02B |
| Net income from continuing operations | 12.01%808.7M | 11.61%4.41B | -20.86%917.7M | 33.02%1.34B | 47.90%1.43B | -11.71%722M | -8.87%3.95B | -3.13%1.16B | -23.40%1.01B | 13.65%968.4M |
| Operating gains losses | -171.34%-139.9M | -144.41%-118.3M | 466.44%212.9M | -206.06%-134.7M | -1,370.55%-392.6M | 17.71%196.1M | 623.91%266.4M | 27.92%-58.1M | 150.10%127M | -81.43%30.9M |
| Depreciation and amortization | 11.22%126.9M | 14.70%482.9M | 11.86%126.4M | 15.46%121.7M | 17.07%120.7M | 14.67%114.1M | 23.32%421M | 12.89%113M | 13.82%105.4M | 38.58%103.1M |
| Deferred tax | 26.94%-139.1M | 9.61%-757.3M | 2.13%-280.2M | -34.13%-168.6M | 43.57%-118.1M | 12.06%-190.4M | -12.25%-837.8M | -2.36%-286.3M | -46.67%-125.7M | -34.17%-209.3M |
| Other non cash items | 3,100.00%3.2M | 36,200.00%36.1M | 488.57%68M | -145.76%-29M | -134.88%-3M | -99.51%100K | -100.02%-100K | -110.36%-17.5M | -119.44%-11.8M | -96.55%8.6M |
| Change In working capital | -70.58%129.6M | -557.07%-618.3M | -40.72%-86.4M | 66.77%-63.9M | -1,017.47%-908.5M | 82.86%440.5M | 61.32%-94.1M | -116.07%-61.4M | 71.18%-192.3M | 89.59%-81.3M |
| -Change in receivables | 47.22%657.8M | -63.52%-554M | -42.44%-117.8M | 16.09%-388.9M | -18,200.00%-494.1M | 112.66%446.8M | -147.87%-338.8M | -137.66%-82.7M | -19.80%-463.5M | 99.16%-2.7M |
| -Change in inventory | 2.25%-152.3M | -128.08%-619.7M | -148.84%-117.7M | -112.95%-164.4M | -81.08%-181.8M | -232.91%-155.8M | 60.99%-271.7M | 67.22%-47.3M | 65.46%-77.2M | 58.18%-100.4M |
| -Change in prepaid assets | -130.42%-179.5M | -239.30%-407.5M | -133.66%-55.3M | 191.47%252M | -15,379.41%-526.3M | -1,316.36%-77.9M | 19.18%-120.1M | 778.61%164.3M | -327.31%-275.5M | 98.60%-3.4M |
| -Change in payables and accrued expense | -293.76%-214.1M | 22.80%735.1M | 262.65%225.6M | -66.40%194.4M | 415.37%204.6M | -7.14%110.5M | 532.51%598.6M | -139.90%-138.7M | 460.95%578.6M | 152.72%39.7M |
| -Change in other working capital | -84.86%17.7M | 501.06%227.8M | -149.30%-21.2M | -5.08%43M | 714.48%89.1M | 425.63%116.9M | 16.98%37.9M | 172.15%43M | 355.93%45.3M | -114.47%-14.5M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -30.90%1.05B | -3.78%4.42B | 15.89%1.26B | 15.88%1.29B | -65.38%354M | 10.60%1.51B | -8.39%4.59B | -36.64%1.09B | 77.18%1.11B | 81.15%1.02B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 138.38%647.5M | 22.51%-2.47B | 629.61%350.6M | -15.74%-574.4M | 76.66%-557.2M | -615.78%-1.69B | 15.84%-3.19B | 96.44%-66.2M | -358.09%-496.3M | -476.69%-2.39B |
| Capital expenditure reported | -71.25%-229.3M | -5.19%-755.9M | 20.60%-199.6M | -37.44%-241.9M | -59.73%-180.5M | 24.86%-133.9M | -21.78%-718.6M | -65.18%-251.4M | -23.51%-176M | 26.43%-113M |
| Net PPE purchase and sale | ---- | --20.1M | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- |
| Net intangibles purchase and sale | -51.25%-42.2M | 39.51%-125.7M | -8.53%-67.4M | --0 | -45.45%-30.4M | 72.35%-27.9M | 79.76%-207.8M | 37.90%-62.1M | 97.42%-23.9M | ---20.9M |
| Net business purchase and sale | ---- | 69.95%-16.5M | -202.63%-11.5M | --0 | ---- | ---- | 76.16%-54.9M | ---3.8M | ---51.1M | ---- |
| Net investment purchase and sale | 160.25%919M | 27.85%-1.59B | 150.54%629.1M | -35.55%-332.5M | 83.96%-361.4M | -3,614.52%-1.53B | -13.75%-2.2B | 115.64%251.1M | -119.44%-245.3M | -7,410.00%-2.25B |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 138.38%647.5M | 22.51%-2.47B | 629.61%350.6M | -15.74%-574.4M | 76.66%-557.2M | -615.78%-1.69B | 15.84%-3.19B | 96.44%-66.2M | -358.09%-496.3M | -476.69%-2.39B |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -2,412.53%-1.09B | -22.93%-2.2B | -154.54%-1.14B | -55.66%-634M | 22.16%-478.1M | 114.60%47.1M | -77.41%-1.79B | -80.17%-446.1M | 43.82%-407.3M | -507.52%-614.2M |
| Net common stock issuance | -2,191.51%-985.1M | -21.06%-2.17B | -154.54%-1.14B | -47.46%-600.6M | 22.16%-478.1M | 114.60%47.1M | -77.41%-1.79B | -80.17%-446.1M | 43.82%-407.3M | -507.52%-614.2M |
| Cash dividends paid | ---93.8M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net other financing activities | ---10.3M | ---33.4M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -2,412.53%-1.09B | -22.93%-2.2B | -154.54%-1.14B | -55.66%-634M | 22.16%-478.1M | 114.60%47.1M | -77.41%-1.79B | -80.17%-446.1M | 43.82%-407.3M | -507.52%-614.2M |
| Net cash flow | ||||||||||
| Beginning cash position | -9.09%2.49B | -12.23%2.74B | -6.87%2.01B | -1.10%1.93B | -33.57%2.61B | -12.23%2.74B | 7.64%3.12B | -38.36%2.16B | -42.80%1.95B | 16.96%3.93B |
| Current changes in cash | 573.25%603.4M | 34.92%-248.1M | -17.23%477.9M | -60.70%82.8M | 65.57%-681.3M | -115.75%-127.5M | -272.25%-381.2M | 249.82%577.4M | 119.02%210.7M | -4,105.47%-1.98B |
| Effect of exchange rate changes | 220.00%600K | -75.00%-700K | -450.00%-700K | 500.00%800K | 25.00%-300K | ---500K | ---400K | --200K | ---200K | ---400K |
| End cash Position | 18.51%3.09B | -9.09%2.49B | -9.09%2.49B | -6.87%2.01B | -1.10%1.93B | -33.57%2.61B | -12.23%2.74B | -12.23%2.74B | -38.36%2.16B | -42.80%1.95B |
| Free cash flow | -42.73%773.6M | -3.51%3.54B | 28.29%995.8M | 14.75%1.05B | -83.89%143.1M | 24.09%1.35B | 7.93%3.67B | -47.11%776.2M | 307.63%914.4M | 116.29%888.5M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025